Literature DB >> 27393549

Xpert(®) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium.

L T Daum1, P B Fourie2, R P H Peters3, J D Rodriguez1, S A Worthy1, M Khubbar4, S Bhattacharyya4, M S Gradus4, T Mboneni2, E E Marubini2, C Helm1, J P Chambers5, G W Fischer1.   

Abstract

BACKGROUND: The Xpert(®) MTB/RIF assay is widely used for Mycobacterium tuberculosis detection. However, specimen transport remains a challenge. PrimeStore Molecular Transport Medium(®) (PS-MTM) inactivates specimens and stabilizes DNA/RNA at ambient temperature for subsequent molecular detection.
OBJECTIVE: To compare the detection of M. tuberculosis concentrations in PS-MTM using Xpert and real-time polymerase chain reaction (RT-PCR), and smear-positive sputum specimens collected using a flocked swab.
METHODS: Dilutions of M. tuberculosis in PS-MTM and phosphate buffered saline (PBS) were analyzed using the Xpert assay and commercial RT-PCR. Smear-positive (1+ to 3+) sputum specimens (n = 17) were transferred by flocked swab into PS-MTM and PBS, and were compared to standard 1.0 ml sputum Xpert analysis.
RESULTS: Using the Xpert assay, cycle threshold values from high M. tuberculosis concentrations in PS-MTM (>10(3) colony forming units [cfu]/ml) were increased compared to control. In contrast, M. tuberculosis samples containing <10(3) cfu/ml, i.e., low concentrations, suspended in PS-MTM resulted in detection down to 10 cfu/ml. Xpert detection efficiency in PS-MTM treated samples (63.2%) was improved compared to PBS controls (34.9%). Xpert detected M. tuberculosis in all sputum specimens collected by flocked swabs in PS-MTM, and correlated with routine Xpert detection.
CONCLUSIONS: PS-MTM enhances M. tuberculosis detection at low concentrations of M. tuberculosis, and provides a simplified and efficient collection method for Xpert detection.

Entities:  

Mesh:

Year:  2016        PMID: 27393549     DOI: 10.5588/ijtld.15.0990

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

1.  Rolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems Strengthening.

Authors:  Ishani Pathmanathan; Anand Date; William L Coggin; John Nkengasong; Amy S Piatek; Heather Alexander
Journal:  Afr J Lab Med       Date:  2017-03-31

2.  PrimeStore MTM and OMNIgene Sputum for the Preservation of Sputum for Xpert MTB/RIF Testing in Nigeria.

Authors:  John S Bimba; Lovett Lawson; Konstantina Kontogianni; Thomas Edwards; Bassey Emanna Ekpenyong; James Dodd; Emily R Adams; Derek J Sloan; Jacob Creswell; Jose Dominguez; Luis E Cuevas
Journal:  J Clin Med       Date:  2019-12-04       Impact factor: 4.241

3.  The Development of a Standardized Quality Assessment Material to Support Xpert® HIV-1 Viral Load Testing for ART Monitoring in South Africa.

Authors:  Lara Dominique Noble; Lesley Erica Scott; Asiashu Bongwe; Pedro Da Silva; Wendy Susan Stevens
Journal:  Diagnostics (Basel)       Date:  2021-01-22

4.  A Comparative Evaluation of the New Genexpert MTB/RIF Ultra and other Rapid Diagnostic Assays for Detecting Tuberculosis in Pulmonary and Extra Pulmonary Specimens.

Authors:  John Osei Sekyere; Nontobeko Maphalala; Lesibana A Malinga; Nontombi M Mbelle; Nontuthuko E Maningi
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

5.  Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.

Authors:  David van Bockel; C Mee Ling Munier; Stuart Turville; Steven G Badman; Gregory Walker; Alberto Ospina Stella; Anupriya Aggarwal; Malinna Yeang; Anna Condylios; Anthony D Kelleher; Tanya L Applegate; Andrew Vallely; David Whiley; William Rawlinson; Phillip Cunningham; John Kaldor; Rebecca Guy
Journal:  Viruses       Date:  2020-10-23       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.